Evidence map›Paper›PMID 39410995›Full record

ArticleFrontiers in neurology2024

Speech motor impairment in ALS is associated with multiregional cortical thinning beyond primary motor cortex.

Ana Luiza Zaninotto, Meena M Makary, Hannah P Rowe, Marziye Eshghi, Chieh-En Jane Tseng, James Chan, Nicole R Zürcher, Jacob Hooker, Austin Lewis, Mackenzie Keegan and 3 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ana Luiza ZaninottoDepartment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, United States.
Meena M MakaryAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Department of Radiology, Harvard Medical School, Boston, MA, United States.
Hannah P RoweDepartment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, United States.
Marziye EshghiDepartment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, United States.
Chieh-En Jane TsengAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Department of Radiology, Harvard Medical School, Boston, MA, United States.
James ChanSean M Healey & AMG Center for ALS, Department of Neurology, Boston, MA, United States.
Nicole R ZürcherAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Department of Radiology, Harvard Medical School, Boston, MA, United States.
Jacob HookerAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Department of Radiology, Harvard Medical School, Boston, MA, United States.
Austin LewisSean M Healey & AMG Center for ALS, Department of Neurology, Boston, MA, United States.
Mackenzie KeeganSean M Healey & AMG Center for ALS, Department of Neurology, Boston, MA, United States.
Ryan F GiffordSean M Healey & AMG Center for ALS, Department of Neurology, Boston, MA, United States.
Jordan R GreenDepartment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, United States.
Suma BabuSean M Healey & AMG Center for ALS, Department of Neurology, Boston, MA, United States.

Funding

Early Biomarkers of Alzheimer's Disease: Using Speech Markers to Detect Mild Cognitive ImpairmentK23DC019179 · NIDCD · MGH INSTITUTE OF HEALTH PROFESSIONS · PI ESHGHI, MARZIYE · 2021 to 2025
$1.1M
NIDCD NIH HHS K23 DC019179
6 · The paper itself

Abstract

Introduction: Cortical thinning is well-documented in individuals with amyotrophic lateral sclerosis (ALS), yet its association with speech deterioration remains understudied. This study characterizes anatomical changes in the brain within the context of speech impairment patterns in individuals with ALS, providing insight into the disease's multiregional spread and biology. Methods: To evaluate patterns of cortical thickness in speakers with ALS with and without functional speech changes compared to healthy controls (HCs) using whole-brain and region of interest (ROI) analyses. Forty individuals with ALS and 22 HCs underwent a T1-weighted 3-Tesla magnetic resonance imaging (MRI). Individuals with ALS were divided into two groups based on the preserved speech [ps-ALS] ( Results: Based on the group-level whole-brain surface-based analyses, the ds-ALS group demonstrated significant cortical thinning compared to HCs in the left primary motor and somatosensory cortices and the right inferior parietal lobe with its adjacent lateral occipital cortical regions. The ps-ALS group demonstrated no significant cortical thinning compared to HCs. Based on the group-level ROI analyses, the ds-ALS group demonstrated significant cortical thinning compared to HCs in bilateral middle motor cortices, right posterior dorsal premotor cortex, and left anterior cingulate cortex. The case study analysis revealed that ALS speakers with speech features characteristic of spastic dysarthria exhibited cortical thinning, while those with speech features characteristic of flaccid dysarthria did not. Discussion: Individuals with ALS have anatomical changes involving multiregional neocortical areas beyond the primary motor cortex that may manifest as subjective (i.e., clinical judgment) and objective (i.e., speaking rate) changes in speech production. Further longitudinal work in ALS is needed to better understand the link between MRI cortical thickness changes and bulbar dysfunction.

Indexed as

amyotrophic lateral sclerosis (ALS)brain atrophydysarthriaMRIneurodegenerationspeech impairmentspeech motor control

Identifiers

PMID39410995
PMCPMC11475245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.